Biogen Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.54B | $3.70B | $3.55B | $2.93B | $1.86B | $1.38B | $1.23B | $1.01B |
| Depreciation & Amortization | $1.08B | $682.7M | $600.4M | $688.1M | $531.7M | $365.6M | $358.9M | $355.7M |
| Depreciation | $266.3M | $309.3M | $217.9M | $198.4M | $187.8M | $164.3M | $143.9M | $144.9M |
| Amortization | $455.3M | $373.4M | $382.6M | $489.8M | $342.9M | $202.2M | $208.6M | $208.9M |
| Stock-Based Compensation | $128.0M | $154.8M | $161.4M | $155.3M | $136.3M | $118.6M | $113.0M | $167.8M |
| Net Cash from Operating Activities | $4.55B | $4.59B | $3.92B | $2.94B | $2.35B | $1.88B | $1.73B | $1.62B |
| Investing Activities | ||||||||
| Capital Expenditures | $867.4M | $616.1M | $643.0M | $287.8M | $246.3M | $254.5M | $208.0M | $173.1M |
| Business Acquisitions | $0 | $0 | $198.8M | $0 | $0 | $72.4M | $5.0M | $72.5M |
| Net Cash from Investing Activities | $-2.96B | $-2.48B | $-4.55B | $-1.54B | $-1.60B | $-950.3M | $-1.65B | $345.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $1.37B | $1.00B | $5.00B | $886.8M | $400.3M | $984.7M | $498.0M | $2.08B |
| Net Cash from Financing Activities | $-2.38B | $-1.05B | $783.1M | $-755.9M | $-716.5M | $-877.5M | $-319.9M | $-1.78B |
| Net Change in Cash | $-792.1M | $1.05B | $148.9M | $643.2M | $23.9M | $52.1M | $-242.4M | $185.1M |
| Free Cash Flow | $3.68B | $3.97B | $3.28B | $2.65B | $2.10B | $1.63B | $1.52B | $1.45B |